性功能障礙與高純度達瑪烷人蔘皂苷相關參考資訊
神戶大學石神襄刺教授,花了三年時間研究, 對於缺乏精子症患者投以人蔘皂苷, 結果顯示, 精子數增加點的有效率達70.8%, 精子運動增加點的有效率達66.6%, 綜合計算 懷孕能力的機率提升到58.3%, 人蔘皂苷的功效, 不僅是強精強壯的效果, 更能徹底改善男性生育能力, 優點遠遠超過威而鋼類的壯陽藥物.
韓國研究證實人蔘皂苷可以治療陽痿,效果不下於威而剛!
分類:兩性關係
2013/01/10 22:03
分享FacebookPlurkYAHOO!
天然威而鋼!韓國人參可治陽痿作者: 華人健康網 記者羅詩樺/編譯 | 華人健康網 – 2013年1月10日 下午3:06
數千年以來,韓國一直都把人參視為十分珍貴的中藥聖品,不僅可降低血糖血壓、肝功能保健,也是幫助性功能的草藥食品,南韓近來一項研究更證實了人參對於治療男性陽痿的功效頗佳,甚至還有可能比藍色小藥丸威而鋼來得強。
美國《醫藥日報》(Medical Daily)報導,過去雖然也有研究指出人參對陽痿有治療效果,但僅限於老鼠為研究對象;而發表於國際性功能障礙期刊(International Journal of Impotence Research)的內容指出,南韓首爾研世大學(Yonsei University)針對100名以上有勃起障礙的男性研究,讓部份受試者服用由韓國人參果實物質所製成的藥丸,另一部份人則使用安慰劑。
由於近10年來對於性功能障礙的輔助藥品僅有像威而鋼(Viagra)、希利士(Cialis)、樂威壯(Levitra)等藥物,且仍有約30%的男性服用後未如預期中有改善效果。研究人員因此轉而尋求傳統草藥的可能性,受試者每天服用4顆人參藥丸,經過8周的時間後,經國際勃起功能障礙指數(International Index of Erectile Dysfunction)測量結果發現,服用人參的組別性功能獲得顯著改善,可望未來讓人參藥丸成為新一代治療陽痿的藥物。
Int J Impot Res. 2013 Apr 18. doi: 10.1038/ijir.2013.19. [Epub ahead of print]
Panax notoginseng saponins improve the erectile dysfunction in diabetic rats by protecting the endothelial function of the penile corpuscavernosum.Lin F, Gou X.
SourceDepartment of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Abstract Diabetes mellitus (DM)-associated ED is predominantly due to neurovascular dysfunction mediated by nitric oxide (NO) suppression. Panax notoginseng saponins (PNS) are widely used for treating cardiovascular disease in China. The aim of this study was to evaluate the effects of PNS on penile erection and corpus cavernosum tissues in rats with diabetes-associated ED. Four weeks after PNS treatment, erectile function was assessed by intracavernous pressure (ICP) and mean arterial pressure (MAP) measurements. The level of NO, cyclic guanosine monophosphate (cGMP) and advanced glycation end products (AGEs) in cavernous tissue were assessed. Immunohistochemical staining and TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling) were performed for detecting endothelial NO synthase (eNOS) and apoptosis, respectively. The results show that ICP/MAP ratio was significantly increased in high-dose (150 mg kg-1 per day) PNS-treated group compared with the diabetic ED untreated group (DM group). Compared with the untreated group, the expression of eNOS and the levels of NO and cGMP were increased in the PNS-treated groups. Moreover, apoptosis was markedly decreased in the group that received 150 mg kg-1 per day of PNS. These results suggest that PNS may be used for improving the ED in diabetic rats via the NO/cGMP pathway and restores the function of endothelium in corpus cavernosum.International Journal of Impotence Research advance online publication, 18 April 2013; doi:10.1038/ijir.2013.19.
PMID: 23595104 [PubMed - as supplied by publisher]
神戶大學石神襄刺教授,花了三年時間研究, 對於缺乏精子症患者投以人蔘皂苷, 結果顯示, 精子數增加點的有效率達70.8%, 精子運動增加點的有效率達66.6%, 綜合計算 懷孕能力的機率提升到58.3%, 人蔘皂苷的功效, 不僅是強精強壯的效果, 更能徹底改善男性生育能力, 優點遠遠超過威而鋼類的壯陽藥物.
韓國研究證實人蔘皂苷可以治療陽痿,效果不下於威而剛!
分類:兩性關係
2013/01/10 22:03
分享FacebookPlurkYAHOO!
天然威而鋼!韓國人參可治陽痿作者: 華人健康網 記者羅詩樺/編譯 | 華人健康網 – 2013年1月10日 下午3:06
數千年以來,韓國一直都把人參視為十分珍貴的中藥聖品,不僅可降低血糖血壓、肝功能保健,也是幫助性功能的草藥食品,南韓近來一項研究更證實了人參對於治療男性陽痿的功效頗佳,甚至還有可能比藍色小藥丸威而鋼來得強。
美國《醫藥日報》(Medical Daily)報導,過去雖然也有研究指出人參對陽痿有治療效果,但僅限於老鼠為研究對象;而發表於國際性功能障礙期刊(International Journal of Impotence Research)的內容指出,南韓首爾研世大學(Yonsei University)針對100名以上有勃起障礙的男性研究,讓部份受試者服用由韓國人參果實物質所製成的藥丸,另一部份人則使用安慰劑。
由於近10年來對於性功能障礙的輔助藥品僅有像威而鋼(Viagra)、希利士(Cialis)、樂威壯(Levitra)等藥物,且仍有約30%的男性服用後未如預期中有改善效果。研究人員因此轉而尋求傳統草藥的可能性,受試者每天服用4顆人參藥丸,經過8周的時間後,經國際勃起功能障礙指數(International Index of Erectile Dysfunction)測量結果發現,服用人參的組別性功能獲得顯著改善,可望未來讓人參藥丸成為新一代治療陽痿的藥物。
Int J Impot Res. 2013 Apr 18. doi: 10.1038/ijir.2013.19. [Epub ahead of print]
Panax notoginseng saponins improve the erectile dysfunction in diabetic rats by protecting the endothelial function of the penile corpuscavernosum.Lin F, Gou X.
SourceDepartment of Urology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Abstract Diabetes mellitus (DM)-associated ED is predominantly due to neurovascular dysfunction mediated by nitric oxide (NO) suppression. Panax notoginseng saponins (PNS) are widely used for treating cardiovascular disease in China. The aim of this study was to evaluate the effects of PNS on penile erection and corpus cavernosum tissues in rats with diabetes-associated ED. Four weeks after PNS treatment, erectile function was assessed by intracavernous pressure (ICP) and mean arterial pressure (MAP) measurements. The level of NO, cyclic guanosine monophosphate (cGMP) and advanced glycation end products (AGEs) in cavernous tissue were assessed. Immunohistochemical staining and TUNEL (terminal deoxynucleotidyl transferase dUTP nick end labeling) were performed for detecting endothelial NO synthase (eNOS) and apoptosis, respectively. The results show that ICP/MAP ratio was significantly increased in high-dose (150 mg kg-1 per day) PNS-treated group compared with the diabetic ED untreated group (DM group). Compared with the untreated group, the expression of eNOS and the levels of NO and cGMP were increased in the PNS-treated groups. Moreover, apoptosis was markedly decreased in the group that received 150 mg kg-1 per day of PNS. These results suggest that PNS may be used for improving the ED in diabetic rats via the NO/cGMP pathway and restores the function of endothelium in corpus cavernosum.International Journal of Impotence Research advance online publication, 18 April 2013; doi:10.1038/ijir.2013.19.
PMID: 23595104 [PubMed - as supplied by publisher]